Search

Author/Creator Van Vollenhoven, R

1. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Issue 4 (3rd April 2008)

Authors:
Gordon, C; Bertsias, G; Ioannidis, J P A; Boletis, J; Bombardieri, S; Cervera, R; Dostál, C; Font, J; Gilboe, I-M; Houssiau, F; Huizinga, T W J; Isenberg, D; Kallenberg, C G M; Khamashta, M A; Piette, J-C; Schneider, M; Smolen, J S; Sturfelt, G; Tincani, A; Van Vollenhoven, R
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 4(2009)
Page Start:
470
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. Issue 4 (13th March 2009)

Authors:
Emery, P; Van Vollenhoven, R; Ostergaard, M; Choy, E; Combe, B; Graninger, W; Krueger, K; Matucci-Cerinic, M; Navarro, F; van Riel, P; Settas, L; Steinfeld, S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 68:Issue 4(2009)
Page Start:
456
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PO.8.186 SLE-T2T – a digital treat-to-target clinical decision support system for the management of systemic lupus erythematosus patients: development and usability evaluation. (27th September 2022)

Authors:
Parra Sanchez, A; Grimberg, MG; Hanssen, MMA; Aben, MO; Jairth, EE; Dhoeme, PS; Tsang-A-Sjoe, M; Voskuyl, A; Leopold, JH; Van Vollenhoven, R
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 2
Page Start:
A130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Issue 3 (8th April 2009)

Authors:
Hanly, J G; Urowitz, M B; Su, L; Bae, S C; Gordon, C; Wallace, D J; Clarke, A; Bernatsky, S; Isenberg, D; Rahman, A; Alarcón, G S; Gladman, D D; Fortin, P R; Sanchez-Guerrero, J; Romero-Diaz, J; Merrill, J T; Ginzler, E; Bruce, I N; Steinsson, K; Khamashta, M
Journal:
Annals of the rheumatic diseases
Issue:
Volume 69:Issue 3(2010)
Page Start:
529
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S11.2 Efficacy and safety of deucravacitinib, a selective TYK2 inhibitor, in patients with active systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (27th September 2022)

Authors:
Van Vollenhoven, R; Pike, M; Merrill, JT; Morand, E; Werth, VP; Hobar, C; Delev, N; Shah, V; Sharkey, B; Wegman, T; Catlett, I; Banerjee, S; Singhal, S
Journal:
Lupus science & medicine
Issue:
Volume 9(2022)Supplement 2
Page Start:
A16
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. SF-36 summary and subscale scores are reliable outcomes of neuropsychiatric events in systemic lupus erythematosus. Issue 6 (21st February 2011)

Authors:
Hanly, J G; Urowitz, M B; Jackson, D; Bae, S C; Gordon, C; Wallace, D J; Clarke, A; Bernatsky, S; Vasudevan, A; Isenberg, D; Rahman, A; Sanchez-Guerrero, J; Romero-Diaz, J; Merrill, J T; Fortin, P R; Gladman, D D; Bruce, I N; Steinsson, K; Khamashta, M; Alarcón, G S
Journal:
Annals of the rheumatic diseases
Issue:
Volume 70:Issue 6(2011)
Page Start:
961
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗